What Are the Goalposts for Present and Future ATTR-CM Therapies?

(MedPage Today) — With several disease-modifying therapies available for transthyretin amyloid cardiomyopathy (ATTR-CM) — and more waiting in the wings — choosing one has become a new challenge, with softer endpoints expected to gain prominence…